pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,081
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
DUET-101
Bladder Cancer
Duet Therapeutics Inc
0
catalysts
Preclinical
DYNE-302
Facioscapulohumeral Muscular Dystrophy (FSHD)
$DYN
Dyne Therapeutics, Inc.
0
catalysts
Preclinical
DaRT-101
Osteoarthritis
Darnatein
0
catalysts
Preclinical
Dekaparin
Deep Vein Thrombosis (DVT)
← prev
page 12 of 37
next →
131
Pain
89
Neurology
1
Glycan Therapeutics Inc
0
catalysts
Preclinical
DisPATCH
Solid Tumor
RootPath Genomics Inc
0
catalysts
Preclinical
Drug for Anal Fissure
Anal Fissure
Steel Therapeutics Inc
0
catalysts
Preclinical
Drug to Inhibit MDM2 for Retinoblastoma
Retinoblastoma
Spectocular LLC
0
catalysts
Preclinical
Drugs for Oncology
Pancreatic Ductal Adenocarcinoma
SRI International
0
catalysts
Preclinical
E-1V111
Spinal Muscular Atrophy (SMA)
Shift Pharmaceuticals
0
catalysts
Preclinical
EB-002
Anxiety Disorders
MycoMedica Life Sciences PBC
0
catalysts
Preclinical
EB-003
Hemolytic Uremic Syndrome
Eligo Bioscience SA
0
catalysts
Preclinical
EB-07
paridiprubart [INN]
Pulmonary Fibrosis
$EDSA
Edesa Biotech, Inc.
0
catalysts
Preclinical
EB-104
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$ESLA
Estrella Immunopharma, Inc.
0
catalysts
Preclinical
EF-005
Alzheimer's Disease
Everfront Biotech Inc
0
catalysts
Preclinical
EG-102
Focal Segmental Glomerulosclerosis (FSGS)
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-201
Wet (Neovascular / Exudative) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-401
Diabetic Retinopathy
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-402
Retinopathy Of Prematurity
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-Mirotin
Diabetic Retinopathy
EyeGene Inc
0
catalysts
Preclinical
EGT-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
0
catalysts
Preclinical
EGT-301
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Esteve Pharmaceuticals SA
0
catalysts
Preclinical
EIR-0205
Dry (Atrophic) Macular Degeneration
EIR Biopharma Inc
0
catalysts
Preclinical
EIR-1003
Neovascular Glaucoma
EIR Biopharma Inc
0
catalysts
Preclinical
EKZ-102
Parkinson's Disease
Eikonizo Therapeutics Inc
0
catalysts
Preclinical
EL-100
Critical Limb Ischemia
Elphis Cell Therapeutics Co Ltd
0
catalysts
Preclinical
EMD-101
Neutropenia
EmendoBio Inc
0
catalysts
Preclinical
EMD-202
Retinitis Pigmentosa (Retinitis)
EmendoBio Inc
0
catalysts
Preclinical
EP-055
Male Contraception
Eppin Pharma Inc
0
catalysts
Preclinical
EPM-301
Prader-Willi Syndrome (PWS)
EPM Group Inc
0
catalysts
Preclinical
EPS-401
Non-Small Cell Lung Cancer
Epsilogen Ltd
0
catalysts
